1. World Health Organization. Leishmaniasis (Internet). Geneva: World Health Organization; 2023 January 12 (cited 2025 January 22). Available from: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis
2. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniasis and other diseases of public health concern. Med Vet Entomol. 2013; 27:123–47.
3. Mokni M. Cutaneous leishmaniasis. Ann Dermatol Venereol. 2019; 146: 232–246.
4. World Health Organization (2008) The Global Burden of Disease: 2004 update. Geneva, Switzerland: World Health Organization. 84 p.
5. Alam MZ, Kovalenko DA, Kuhls K, et al. Identification of the agent causing visceral leishmaniasis in Uzbeki and Tajiki foci by analyzing parasite DNA extracted from patients' Giemsa-stained tissue preparations. Parasitology. 2009;136(9):981-6.
6. Kovalenko DA, Razakov SA, Ponirovsky EN, et al. Canine leishmaniosis and its relationship to human visceral leishmaniasis in Eastern Uzbekistan. Parasit Vectors. 2011; 4:58.
7. Usarov GX, Turitsin VS, Sattarova XG, et al. Phlebotomine sand fly (Diptera: Phlebotominae) diversity in the foci of cutaneous leishmaniasis in the Surxondaryo Region of Uzbekistan: 50 years on. Parasitol Res. 2024;123(3):170.
8. World Health Organization. Number of cases of cutaneous and visceral leishmaniasis reported (Internet). Geneva: World Health Organization; (cited 2025 January 22). Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/number-of-cases-of-cutaneous-leishmaniasis-reported
9. World Health Organization. Number of cases of cutaneous and visceral leishmaniasis reported (Internet). Geneva: World Health Organization; (cited 2025 January 22). Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/number-of-cases-of-visceral-leishmaniasis-reported
10. Burza S, Croft SL, Boelaert M (2018). Leishmaniasis. Lancet. 2018; 392(10151):951-970.
11. van Henten S, Adriaensen W, Fikre H, et al. Cutaneous leishmaniasis due to Leishmania aethiopica. EClinicalMedicine. 2019; 6:69-81.
12. Azeredo-Coutinho RB, Conceição-Silva F, Schubach A, et al. First report of diffuse cutaneous leishmaniasis and Leishmania amazonensis infection in Rio de Janeiro State, Brazil. Trans R Soc Trop Med Hyg. 2007;101(7):735–737.
13. Hajjaran H, Mohebali M, Akhavan AA, et al. Unusual presentation of disseminated cutaneous leishmaniasis due to Leishmania major: Case reports of four Iranian patients. Asian Pac J Trop Med. 2013; 6(4):333-6.
14. Artamonova OG, Monchakovskaya ES, Kubanov AA, et al. A rare form of leishmaniasis, identified in the Russian Federation. Vestnik Dermatologii i Venerologii. 2023;99(3):79–86.
15. Gelanew T, Hurissa Z, Diro E, et al. Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia. Am J Trop Med Hyg. 2011;84(6):906-12.
16. Badirzadeh AR, Mohebali M, Sabzevari S, et al. Case Report: First Coinfection Report of Mixed Leishmania infantum/Leishmania major and Human Immunodeficiency Virus–Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Iran. Am J Trop Med Hyg, 2018; 98(1):122–125.
17. Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2017;96(1):24-45.
18. Khamdamov BZ, Rasulova IA, Khamdamov AB. Clinical and epidemiological features of cutaneous leishmaniasis in the regions of Uzbekistan. JournalNX: A Multidisciplinary Peer Reviewed Journal. 2022; 8(4):169-173.
19. Shafiei R, Mohebali M, Akhoundi B, et al. Emergence of coinfection of visceral leishmaniasis in HIV-positive patients in northeast Iran: a preliminary study. Travel Med Infect Dis. 2014; 12(2):173–178.
20. Kassardjian AA, Yim KM, Rabi S, et al. Diffuse cutaneous leishmaniasis and HIV co-infection: A case report and review of the literature. J Cutan Pathol. 2021;48(6):802–806.
21. Jafari S, Hajiabdolbaghi M, Mohebali M, et al. Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran. East Mediterr Health J. 2010; 16(3): 340–343.
22. Nissapatorn V, Sawangjaroen N. Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges. Indian J Med Res. 2011; 134(6):878-97.
23. Van Griensven J, Carrillo E, López-Vélez R, et al. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014; 20(4):286-99.